D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 91 Citations 32,435 282 World Ranking 5718 National Ranking 3173

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Acquired immunodeficiency syndrome

David B. Clifford mainly focuses on Internal medicine, Immunology, Progressive multifocal leukoencephalopathy, Viral load and JC virus. His Internal medicine research is multidisciplinary, incorporating perspectives in Peripheral neuropathy, Efavirenz and Oncology. His Immunology study integrates concerns from other disciplines, such as Gastroenterology and Cerebrospinal fluid.

The Viral load study combines topics in areas such as Neuropathic pain, HIV-associated neurocognitive disorder, Regimen, Hepatitis C and Neurocognitive. His Neurocognitive research includes elements of Acquired immunodeficiency syndrome and Depression. His research integrates issues of Disease and Pathology in his study of JC virus.

His most cited work include:

  • Updated research nosology for HIV-associated neurocognitive disorders (1808 citations)
  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. (1548 citations)
  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors (1050 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Immunology, Progressive multifocal leukoencephalopathy, Neurocognitive and Acquired immunodeficiency syndrome are his primary areas of study. His biological study spans a wide range of topics, including Gastroenterology, Peripheral neuropathy, Viral load and Oncology. As a part of the same scientific study, David B. Clifford usually deals with the Immunology, concentrating on Cerebrospinal fluid and frequently concerns with Pharmacology.

His study in Progressive multifocal leukoencephalopathy is interdisciplinary in nature, drawing from both Natalizumab, Leukoencephalopathy, Disease and Pathology. His research investigates the connection between Neurocognitive and topics such as HIV-associated neurocognitive disorder that intersect with problems in Cognitive disorder. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Pediatrics.

He most often published in these fields:

  • Internal medicine (35.31%)
  • Immunology (24.33%)
  • Progressive multifocal leukoencephalopathy (18.10%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (35.31%)
  • Disease (11.87%)
  • Neurocognitive (14.84%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Disease, Neurocognitive, Immunology and Progressive multifocal leukoencephalopathy. His studies in Internal medicine integrate themes in fields like Gastroenterology, Viral load, Oncology and Coinfection. His Disease study integrates concerns from other disciplines, such as Pathogenesis, Sarcoidosis, Neurosarcoidosis, Intensive care medicine and Clinical endpoint.

His Neurocognitive research is multidisciplinary, incorporating elements of Cross-sectional study, Confounding, Dementia and HIV-associated neurocognitive disorder. In his work, RNA and Optimal treatment is strongly intertwined with Antiretroviral therapy, which is a subfield of Immunology. His Progressive multifocal leukoencephalopathy research integrates issues from Natalizumab and Cancer research.

Between 2015 and 2021, his most popular works were:

  • The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model (123 citations)
  • Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. (87 citations)
  • Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients (79 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Pathology

David B. Clifford focuses on Immunology, Neurocognitive, Internal medicine, Disease and HIV-associated neurocognitive disorder. His Immunology study combines topics from a wide range of disciplines, such as Cerebrospinal fluid and Cohort. David B. Clifford combines subjects such as Psychosocial, Acquired immunodeficiency syndrome, Asymptomatic, Dementia and Neurology with his study of Neurocognitive.

His studies deal with areas such as JC virus and Progressive multifocal leukoencephalopathy as well as Neurology. His Internal medicine study incorporates themes from Gastroenterology, White matter, Oncology and Coinfection. His work carried out in the field of HIV-associated neurocognitive disorder brings together such families of science as Single-nucleotide polymorphism and Cognition.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Updated research nosology for HIV-associated neurocognitive disorders

A. Antinori;G. Arendt;J. T. Becker;B. J. Brew.
Neurology (2007)

2459 Citations

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

R. K. Heaton;D. B. Clifford;D. R. Franklin;S. P. Woods.
Neurology (2010)

2079 Citations

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Robert K. Heaton;Donald R. Franklin;Ronald J. Ellis;J. Allen McCutchan.
Journal of NeuroVirology (2011)

1398 Citations

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

Tarek A. Yousry;Eugene O. Major;Caroline Ryschkewitsch;Gary Fahle.
The New England Journal of Medicine (2006)

890 Citations

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Scott Letendre;Jennifer Marquie-Beck;Edmund Capparelli;Brookie Best.
JAMA Neurology (2008)

887 Citations

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney.
AIDS (2004)

732 Citations

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt.
Lancet Neurology (2010)

675 Citations

PML diagnostic criteria: Consensus statement from the AAN neuroinfectious disease section

Joseph R. Berger;Allen J. Aksamit;David B. Clifford;Larry Davis.
Neurology (2013)

509 Citations

HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen.
Journal of Acquired Immune Deficiency Syndromes (2012)

502 Citations

HIV-associated neurocognitive disorder

David B Clifford;Beau M Ances.
Lancet Infectious Diseases (2013)

454 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David B. Clifford

Scott Letendre

Scott Letendre

University of California, San Diego

Publications: 164

Igor Grant

Igor Grant

University of California, San Diego

Publications: 159

Ronald J. Ellis

Ronald J. Ellis

University of California, San Diego

Publications: 152

Steven Paul Woods

Steven Paul Woods

University of Houston

Publications: 149

Bruce J. Brew

Bruce J. Brew

University of New South Wales

Publications: 135

Robert K. Heaton

Robert K. Heaton

University of California, San Diego

Publications: 107

Igor J. Koralnik

Igor J. Koralnik

Northwestern University

Publications: 88

Justin C. McArthur

Justin C. McArthur

Johns Hopkins University School of Medicine

Publications: 86

Avindra Nath

Avindra Nath

National Institutes of Health

Publications: 81

Richard W. Price

Richard W. Price

University of California, San Francisco

Publications: 78

Magnus Gisslén

Magnus Gisslén

Sahlgrenska University Hospital

Publications: 71

Susan Morgello

Susan Morgello

Icahn School of Medicine at Mount Sinai

Publications: 69

David W. Haas

David W. Haas

Vanderbilt University

Publications: 67

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 63

Joseph R. Berger

Joseph R. Berger

University of Pennsylvania

Publications: 63

Beau M. Ances

Beau M. Ances

Washington University in St. Louis

Publications: 55

Trending Scientists

Michael Biehl

Michael Biehl

University of Groningen

Thierry Siméon

Thierry Siméon

Federal University of Toulouse Midi-Pyrénées

Ji-Qing Lu

Ji-Qing Lu

Zhejiang Normal University

Daniel M. Dauer

Daniel M. Dauer

Old Dominion University

Scott A. Beatson

Scott A. Beatson

University of Queensland

Claude E. Boyd

Claude E. Boyd

Auburn University

Andreas Conzelmann

Andreas Conzelmann

University of Fribourg

Hans-Georg Kräusslich

Hans-Georg Kräusslich

Heidelberg University

Jean-Francois Hausman

Jean-Francois Hausman

United States Department of Agriculture

Sergio Fagherazzi

Sergio Fagherazzi

Boston University

Qi Ying

Qi Ying

Texas A&M University

Loreta Medina

Loreta Medina

University of Lleida

Howard M. Cooper

Howard M. Cooper

Claude Bernard University Lyon 1

Stefano Pallanti

Stefano Pallanti

Albert Einstein College of Medicine

Jeffrey A. Kelly

Jeffrey A. Kelly

Medical College of Wisconsin

W. Timothy Garvey

W. Timothy Garvey

University of Alabama at Birmingham

Something went wrong. Please try again later.